2026
V2 | Vplyv selektívnych peptidových látok na vývoj kuracieho embrya David Frandel, Ľudmila Balážová, Tomáš Wolaschka Študentská vedecká konferencia |
2025
V3 | Biosynthesis of silver nanoparticles using medicinal plants Tomáš Wolaschka, Simona Rohaľová, Zdenka Bedlovičová, Aneta Salayová, Matej Baláž, Ľudmila Tkáčiková, Ľudmila Balážová European Pharmaceutical JournalSJR Q 4SJR 0.12H-index 9Metrics year 2024 |
2025
V3 | Formulation of stimuli-responsive gels containing silver complex with nicotinamide Tomáš Wolaschka, Simona Rohaľová, Ivana Průšová, Simona Hisirová, Dagmar Mudroňová, Zuzana Vargová European Pharmaceutical JournalSJR Q 4SJR 0.12Metrics year 2024 |
2025
V3 | Formulation of stimuli-responsive gels containing silver complex with nicotinamide Tomáš Wolaschka, Simona Rohaľová, Ivana Průšová, Simona Hisirová, Dagmar Mudroňová, Zuzana Vargová European Pharmaceutical JournalSJR Q 4SJR 0.12H-index 9Metrics year 2024 |
2025
V3 | In situ gély v gastrointestinálnych a vaginálnych aplikáciách Tomáš Wolaschka, Simona Rohaľová, Ivana Průšová, Zuzana Helmeciová Folia Pharmaceutica Cassoviensia |
2025
V3 | In situ gély v parenterálnych a topických aplikáciách Tomáš Wolaschka, Simona Rohaľová Folia Pharmaceutica Cassoviensia |
2025
V3 | Utilizing CO2 for ultrafast mechanosynthesis of calcite with potential pharmaceutical applications as a sustained-release medicine Erika Tóthová, Dominika Kučerová, Tomáš Wolaschka, Martin Kello, Matej Baláž, Zdenka Lukáčová Bujňáková, Michal Hegedüs Journal of environmental chemical engineeringIF 7.5IF5 7.7SJR Q 1JCR Q 1SJR 1.273H-index 172ABDC 0.939Metrics year 2025 |
2024
V3 | Antibacterial activity of plant-derived compounds and cream formulations against canine skin bacteria Viola Strompfová, Lucia Štempelová, Tomáš Wolaschka Veterinary Research CommunicationsIF 2IF5 2.1SJR Q 1JCR Q 2SJR 0.568H-index 65ABDC 0.392Metrics year 2024 |
2024
V3 | Formulation optimization and evaluation of oromucosal in situ gel loaded with silver nanoparticles prepared by green biosynthesis Simona Rohaľová, Tomáš Wolaschka, Ľudmila Balážová, Katarína Paulovičová, Jana Tóthová, Sylvie Pavloková, Martin Stahorský, Jan Gajdziok European Journal of Pharmaceutical SciencesIF 4.7IF5 4.4SJR Q 1JCR Q 1SJR 0.827H-index 170ABDC 0.719Metrics year 2024 |
2024
P1 | Klinická a patologická biochémia pre študijný program farmácia Marcela Valko-Rokytovská, Jana Šimková, Mária Milkovičová, Zuzana Kostecká, Peter Očenáš, Tomáš Wolaschka; rec. Lenka Varinská, Martina Orosová |
2024
O2 | Miconazole and acetamiprid as regulators of cell cycle, apoptosis and signaling pathways associated with their cytotoxic effects in vitro Šimon Salanci, Viera Schwarzbacherová, Tomáš Wolaschka, Radka Michalková Student scientific international conference “GenICa” |
2023
V3 | Evaluation of in situ gels intended for oromucosal delivery Simona Rohaľová, Tomáš Wolaschka, Katarína Paulovičová, Jana Tóthová, Jan Gajdziok European Pharmaceutical JournalSJR Q 4SJR 0.117H-index 8Metrics year 2022 |
2023
V3 | Evaluation of thermosensitive polymers for the formulation of oral in situ gel Simona Rohaľová, Tomáš Wolaschka, Kristína Juhasová, Katarína Paulovičová, Jana Tóthová Folia Pharmaceutica Cassoviensia |
2023
V3 | In situ gel with silver nanoparticles prepared using Agrimonia eupatoria L. shows antibacterial activity Ľudmila Balážová, Tomáš Wolaschka, Simona Rohaľová, Nina Daneu, Martin Stahorský, Aneta Salayová, Ľudmila Tkáčiková, Jarmila Eftimová LifeIF 3.2IF5 3.1SJR Q 1JCR Q 1SJR 0.713ABDC 0.655Metrics year 2023 |
2023
V3 | Pilot formulation study of pH-sensitive gels Tomáš Wolaschka, Simona Rohaľová, Ivana Želinská, Ľudmila Balážová, Miriam Bačkorová, Slavomír Kurhajec European Pharmaceutical JournalSJR Q 4SJR 0.148Metrics year 2023 |
2023
V3 | Possibilities of plant drugs incorporation into the tablets Slavomír Kurhajec, Aleš Franc, Tomáš Wolaschka, Simona Rohaľová European Pharmaceutical JournalSJR Q 4SJR 0.117H-index 8Metrics year 2022 |
2023
V3 | Thermosensitive in situ gel with biosynthetized silver nanoparticles shows antibacterial activity Ľudmila Balážová, Tomáš Wolaschka, Simona Rohaľová, Nina Daneu, Martin Stahorský, Aneta Salayová, Ľudmila Tkáčiková, Lenka Kozubová, Jarmila Eftimová European Pharmaceutical JournalSJR Q 4SJR 0.117H-index 8Metrics year 2022 |
2022
O2 | Antibakteriálna aktivita éterických olejov voči bakteriálnym patogénom rýb Jana Koščová, Vanda Hajdučková, Tomáš Wolaschka, Adriána Fečkaninová 29. kongres Československé společnosti mikrobiologické s mezinárodní účastí, 28. Moravsko-slovenské mikrobiologické dny, 31. Tomáškovy dny mladých mikrobiologů |
2022
V3 | Beta-blockers in the treatment of hypertension and tablet formulation Tomáš Wolaschka, Dominik Kľoc, Simona Rohaľová, Filip Ruttkay Folia Pharmaceutica Cassoviensia |
2022
V3 | Formulation of transdermal system with non-selective beta-blocker propranolol Tomáš Wolaschka, Simona Rohaľová, Dominik Kľoc, Adriána Fečkaninová, Matúš Guman Folia Pharmaceutica Cassoviensia |
